VB
Vikas Bhardwaj
Medical Technologist, AIIMS New Delhi
Updated: Apr 17, 2026
**Core Concept**
The pathogenesis of the likely disorder described here involves an imbalance of hormonal influences on the prostate gland, specifically an increase in androgens. This imbalance can lead to the growth and proliferation of prostate cells, resulting in an enlarged prostate.
**Why the Correct Answer is Right**
The correct answer is related to the role of dihydrotestosterone (DHT) in the pathogenesis of benign prostatic hyperplasia (BPH). DHT is a potent androgen that is produced from testosterone by the enzyme 5-alpha-reductase. DHT promotes the growth and proliferation of prostate cells, leading to an enlarged prostate. The increase in serum PSA is also consistent with BPH, as PSA is produced by the prostate gland and can be elevated in the presence of an enlarged prostate.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because testosterone itself is not the primary androgen involved in the pathogenesis of BPH. While testosterone does contribute to the growth and maintenance of the prostate gland, it is DHT that is more directly involved in the development of BPH.
* **Option B:** This option is incorrect because estrogen is not a primary hormone involved in the pathogenesis of BPH. In fact, estrogen can have a suppressive effect on prostate growth.
* **Option C:** This option is incorrect because 5-alpha-reductase inhibitors, such as finasteride, are actually used to treat BPH by blocking the conversion of testosterone to DHT. They are not involved in the pathogenesis of the disorder.
**Clinical Pearl / High-Yield Fact**
It's worth noting that the presence of a modestly increased serum PSA in the context of an enlarged prostate and symptoms of urinary obstruction suggests BPH rather than prostate cancer. A PSA level of less than 10 ng/mL is generally considered normal, and a level between 10-20 ng/mL may indicate BPH.
**Correct Answer: C. Dihydrotestosterone (DHT)**